Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-15-081133

Chief Medical Officer acquired 5,022 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kaye Randall Chief Medical Officer 2015-11-24 Conversion +5,022 $5.40 $27,119 5,022 D
Derivatives
Kaye Randall Chief Medical Officer 2015-11-24 Grant or award · 8% Convertible Note +5,022 0 D
Loading xslF345X03/a4.xml…